Myoclonic Epilepsy
📧 Sign up to get email alerts when something new happens for Myoclonic Epilepsy.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-06-08EMA Authorised: Fintepla (fenfluramine hydrochloride) — UCB Pharma S.A.
The EMA authorised Fintepla (fenfluramine hydrochloride) from UCB Pharma S.A. for epilepsies with myoclonic seizures, an orphan medicine des…
-
EMA approval · 2026-04-09EMA Authorised: Fintepla (fenfluramine hydrochloride) — UCB Pharma S.A.
The EMA authorised Fintepla (fenfluramine hydrochloride) for epilepsies with myoclonic features, with orphan medicine designation; decision …